Case report. Successfully treated subcutaneous infection with Sporothrix schenckii in Turkey

Mycoses

Volumn 44, Issue 7-8, 2001, Pages 330-333

  Koç, A Nedret ^a   Uksal U ^b   Oymak, O ^b  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b NONE

Author keywords

Antimycotic chemotherapy; Itraconazole; Potassium iodide; Sporothrix schenckii; Sporotrichosis; Subcutaneous infection

Indexed keywords

ITRACONAZOLE; POTASSIUM IODIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CULTURE MEDIUM; DISEASE COURSE; FUNGUS ISOLATION; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; NONHUMAN; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS; TREATMENT OUTCOME; TURKEY (REPUBLIC);

ANTIFUNGAL AGENTS; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; POTASSIUM IODIDE; SPOROTHRIX; SPOROTRICHOSIS; TURKEY;

FUNGI; SPOROTHRIX; SPOROTHRIX SCHENCKII;

EID: 0035788133     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2001.00637.x     Document Type: Article

References (15)

1. Schell, W. A., Pasarell, L., Salkým, I. F. & McGinnis, M. R. (1995) Bipolaris, Exophiala, Scedosporium, Sporothrix, and other dematiaceous fungi. In: Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H. (eds) Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology, pp. 825-846.
2. De Hoog, G. S. & de Vries, G. A. (1973) Two new species of Sporothrix schenckii and their relation to Blostobotrys nivea Antonie van Leeuwenhoek. J. Microbiol. 39, 515-510.
3. Sigler, L., Harris, J. L., Dixon, D. M., et al. (1990) Microbiology and potential virulence of Sporothrix cyanescens, a fungus rarely isolated from blood and skin. J Clin. Microbiol. 28, 1009-1015.
4. National Committee for Clinical Laboratory Standards. (1995) Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts. Proposed standard M27-T. Villanova, PA: National Committee for Clinical Laboratory Standards.
5. Mitchell, T. G. (1992) Subcutaneous mycoses. In: Joklik, W. K., Willett, H. P., Amos, D. B. & Wilfert, C. M. (eds) Microbiology. California: Appleton and Lange, pp. 1113-1124.
6. Rex, J. H. (1995) Sporothrix schenckii. In: Mandell, G. L., Bennett, J. E., Dolin, R. (eds) Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 4th edn, Vol. 2. New york: Churchill Livingstone, pp. 2321-2324.
7. Hardara, M., Fuat, (1910) Trois cas de sporotrichose de Beurmann. Bull. Méd. Const. 2, 98.
8. Sargin, C., Yücel, A. & Yilmaz, S. (1964) Yaygin bir sporotrikoz vakasi. Istanbul U Med. Publications 27, 38.
9. Itoh, M., Okamoto, S. & Kariya, H. (1986) Survey of 200 cases of sporotrichosis. Dermatologica 172, 209-213.
10. Pluss, J. L. & Opal, S. M. (1986) Pulmonary sporotrichosis. Rev. Treatment Outcome. Med. 65, 143-153.
11. Restrepo, A., Robledo, J., Gomez, I., Tabares, A. M. & Gutierrez, R. (1986) Itraconazole therapy in lymphagitic and cutaneous sporotrichosis. Arch. Dermatol. 122, 413-417.
12. Conti Diaz, I. A., Civila, E., Gezuele, E., et al. (1992) Treatment of human cutaneous sporotrichosis with itraconazole. Mycoses 35, 153-156.
13. Al-Tawfinq, J. A. & Wools, K. K. (1998) Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin. Infec. Dis. 26, 1403-1406.
14. Espinel Ingroff, A. (1998) In vitro activity of the new triazole voriconazole (UK-109, 496) against opportunistic filamentous and emerging yeast pathogens. J. Clin. Microbiol. 36, 198-202.
15. Fung-Tomc, J. C., Huczko, E., Minassian, B. & Bonner, D. P. (1998) In vitro activity of new oral triazole, BMS-207147 (ER-30346) Antimicrob. Agents. Chemother. 42, 313-318.